SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

RIGL

Rigel Pharmaceuticals, Inc.
NASDAQHealth Care

Latest close: 45.97 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 4, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 4, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Jul 1, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,32718 flagged findings
Reported transactions (Form 4)80since Jan 29, 2025 · and 2 other holdings
Corporate events (8-K)30since May 21, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-08-04share offering or dilution eventfreshOpen filing ↗
    “…Part I, Item 1 of this Quarterly Report on Form 10-Q. We have an Open Market Sale Agreement with Jefferies LLC (Jefferies), as a…”
    +1 more passage from the same document
    • “…additional capital in the future to continue to expand our business, we may conduct additional equity offerings. We have an Open…”
  • 2026-08-04capital return (buybacks/dividends)freshOpen filing ↗
    “…of shares that may yet be purchased under the plans or programs April 1 - April 30 101 $ 27.50 — — May 1 - May 31 630 $ 30.77 — —…”
    +1 more passage from the same document
    • “…shares that may yet be purchased under the plans or programs April 1 - April 30 101 $ 27.50 — — May 1 - May 31 630 $ 30.77 — — June…”
  • 2026-08-04regulatory investigationfreshOpen filing ↗
    “…to damages, fines, penalties or other criminal, civil or administrative sanctions or enforcement actions. We cannot ensure that…”
    +1 more passage from the same document
    • “…errors associated with our submission of pricing data and for any overcharging of government payors. Failure to make 59 Table of…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:10 on Jun 27, 2024) · 1:10 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,327)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 8.9% · event on Jun 30, 26 · amendment
  • Aug 13, 26SCHEDULE 13G/A ↗Passive stake · Soleus Capital Master Fund, L.P. · 9.9% · event on Jun 30, 26 · amendment
  • Aug 4, 268-K ↗Current report · Results
  • Aug 4, 2610-Q ↗Quarterly report
  • Jul 10, 26Form 4 ↗Insider transaction
  • Jul 1, 268-K ↗Current report · A senior executive left or was appointed
  • Jun 24, 26Form 4 ↗Insider transaction
  • Jun 22, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 5 Form 4 filingsshow all 5hide
  • Jun 17, 268-K ↗Current report · Completed an acquisition or disposal
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • May 26, 26Form 144 ↗Notice of proposed sale

1,327 filings on record, the oldest from Dec 14, 00.

Listing the 25 most recent filings of the 1,327 on record.

8-Ks, explained

Stress7Structure31Governance63
  • Jul 1, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Jun 17, 26StructureCompleted an acquisition or disposal8-K 2.01 ↗
  • May 20, 26GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • May 12, 26StructureEntered a material agreement8-K 1.01 ↗
  • Apr 21, 26StructureA material agreement was terminated8-K 1.02 ↗
  • Governance4 senior executive changes2024 – 2026show all 4hide
    • Feb 3, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • May 23, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Mar 10, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Sep 19, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Sep 3, 24StructureEntered a material agreement8-K 1.01 ↗
  • May 29, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 12, 24StructureEntered a material agreement8-K 1.01 ↗
  • Feb 22, 24StructureCompleted an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
  • Nov 30, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • May 30, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗

11 older filings not shown · The record reaches back to Oct 4, 04.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

  • Nov 29, 22StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Oct 11, 22StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
  • Nov 15, 21StressRestructuring plan with committed costs8-K 2.05 ↗
  • Sep 15, 16StressRestructuring plan with committed costs+2 more in the same filing8-K 2.05 ↗
  • Feb 3, 09StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
  • Oct 6, 06StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗

The full record holds 7 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Soleus Capital Master Fund, L.P.9.9%Jun 30, 26SCHEDULE 13G/A ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Armistice Capital, LLC8.9%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 5 earlier filings
  • BlackRock, Inc.7.7%Mar 31, 25SCHEDULE 13G/A ↗1 earlier filing
  • STATE STREET CORPORATION6.0%Dec 31, 25SCHEDULE 13G ↗
  • Morgan Stanley0.7%Sep 30, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Jun 22, Ali-Jackson Kamil filed notice of intent to sell up to $88K. That is about 0.01% of shares outstanding. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $88K on Jun 22, per their Form 4. That is 100% of the shares announced.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Jun 22, 26Sell$88KKamil Ali-Jackson↗
  • May 26, 26Sell$73KKamil Ali-Jackson↗
  • Feb 20, 26Sell$145KWALTER H MOOS↗
Stock compensation, tax and giftsshow the 37 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 2, 26Compensation$9KDean L SchornoEVP & Chief Financial Officer↗
  • Sep 2, 26Compensation$12KDean L SchornoEVP & Chief Financial Officer↗
  • Sep 2, 26Compensation$48KDean L SchornoEVP & Chief Financial Officer↗
  • Sep 2, 26Compensation$31KDean L SchornoEVP & Chief Financial Officer↗
  • Sep 1, 26Tax$42KRaymond J. FureyEVP, GC, CCO & Corp Sec↗
  • Sep 1, 26Tax$115KRAUL R RODRIGUEZCEO, President↗
  • Sep 1, 26Tax$42KDavid A SantosEVP, Chief Commercial Officer↗
  • Sep 1, 26Tax$44KDean L SchornoEVP & Chief Financial Officer↗
  • Jul 8, 26Compensationamount n/aALISON L. HANNAHEVP, Chief Medical Officer↗
  • Jun 1, 26Tax$26KRaymond J. FureyEVP, GC, CCO & Corp Sec↗
  • Jun 1, 26Tax$72KRAUL R RODRIGUEZCEO, President↗
  • Jun 1, 26Tax$25KLisa RojkjaerEVP, Chief Medical Officer↗
  • Jun 1, 26Tax$26KDavid A SantosEVP, Chief Commercial Officer↗
  • Jun 1, 26Compensation$22KDean L SchornoEVP & Chief Financial Officer↗
  • Jun 1, 26Compensation$28KDean L SchornoEVP & Chief Financial Officer↗
  • Jun 1, 26Tax$28KDean L SchornoEVP & Chief Financial Officer↗
  • May 15, 26Compensationamount n/aKamil Ali-Jackson↗
  • May 15, 26Compensationamount n/aMark W Frohlich↗
  • May 15, 26Compensationamount n/aALISON L. HANNAH↗
  • May 15, 26Compensationamount n/aANTHONY GREGG LAPOINTE↗
  • May 15, 26Compensationamount n/aMICHAEL PATRICK MILLER↗
  • May 15, 26Compensationamount n/aWALTER H MOOS↗
  • May 15, 26Compensationamount n/aJane Wasman↗
  • Feb 20, 26Compensation$96KWALTER H MOOS↗
  • Feb 17, 26Compensationamount n/aDean L SchornoEVP & Chief Financial Officer↗
  • Feb 17, 26Compensationamount n/aLisa RojkjaerEVP, Chief Medical Officer↗
  • Feb 17, 26Compensationamount n/aDavid A SantosEVP, Chief Commercial Officer↗
  • Feb 17, 26Compensationamount n/aRAUL R RODRIGUEZCEO, President↗
  • Feb 17, 26Compensationamount n/aRaymond J. FureyEVP, GC, CCO & Corp Sec↗
  • Feb 10, 26Tax$263KRAUL R RODRIGUEZCEO, President↗
  • Feb 10, 26Tax$123KRaymond J. FureyEVP, GC, CCO & Corp Sec↗
  • Feb 10, 26Tax$130KLisa RojkjaerEVP, Chief Medical Officer↗
  • Feb 10, 26Tax$123KDean L SchornoEVP & Chief Financial Officer↗
  • Feb 10, 26Tax$123KDavid A SantosEVP, Chief Commercial Officer↗
  • Feb 2, 26Tax$143KRaymond J. FureyEVP, GC, CCO & Corp Sec↗
  • Feb 2, 26Tax$198KDean L SchornoEVP & Chief Financial Officer↗
  • Feb 2, 26Tax$206KDavid A SantosEVP, Chief Commercial Officer↗

The full record holds 101 transactions and goes back to Jan 26, 23.

Its sector and its market

Rigel Pharmaceuticals, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Rigel Pharmaceuticals, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Rigel Pharmaceuticals, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,327 documents on file, from Dec 14, 2000 to Sep 3, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.